HE.Com’s Weekly News is Here! What Did You Miss?

What impact will ICER reports have in Europe? Should value frameworks for rare disease be different? How is the current uncertainty in healthcare affecting you? Could your advisory board benefit from a medical writer? Read more about all of these topics and more in HealthEconomics.Com’s latest newsletter. If you would like to sign up and receive our weekly newsletter in your inbox, sign up here.

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
Biomarkers and Companion diagnostics: Payer Insights September 26, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
Current Landscape: Value Assessment Frameworks October 23, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
New Non-Profit Association Launches Free Guideline… January 16, 2019
Review of Influence: The Institute for Clinical and Economic Review February 26, 2019